Supply of AstraZeneca medicines
Our modern and simplified supply and delivery service ensures that all community pharmacies, dispensing doctors and hospitals will have the right medicine, delivered to the right place, for every patient, every time.
Supply of Medicines
We are working to a shared agenda with the NHS, healthcare professionals and the Government in delivering effective and efficient healthcare to patients. Our agent supply network ensures a modern and effective supply and delivery service is in place at all times.
AstraZeneca's Supply and Delivery Service
A review of how AstraZeneca medicines reached patients in the UK during 2007 highlighted opportunities to simplify and modernise the existing system to help us ensure that our medicines are delivered to those who need them, when they need them.
We now deliver our medicines directly to customers in the UK through two agency partners AAH Pharmaceuticals Ltd and Phoenix.
We are supplying our medicines directly to the NHS with the help of our agency partners, instead of supplying them indirectly through a wholesaling system.
This more direct relationship, allows us to have a direct channel of communication and to better understand the needs of our customers and the UK Pharmaceutical supply chain environment.
Our supply chain allows us to partner more directly with our customers to:
- Ensure a modern effective supply and delivery service is in place at all times
- Make sure our medicines are delivered to those who need them, when they need them
Depots throughout the UK giving you choice and meeting your needs
Supply of Fluenz® Tetra (nasal spray, suspension influenza vaccine (live attenuated))
This web page provides information to healthcare professionals on how to obtain supply of Fluenz Tetra.
Stock can be ordered via Immform for the National Flu programme.
If you wish to purchase stocks for anyone outside of the groups covered in the national programme but within licence, please contact 08451 390000 to purchase Fluenz Tetra.
For private purchases, Fluenz Tetra is supplied by AstraZeneca's standard terms and conditions of supply, subject to the following additional provisions:
Fluenz Tetra requires cold chain storage and it is your responsiblity to ensure that it is kept in the proper conditions at all times.
Fluenz Tetra is not provided on a "sale or return" basis: if you do not sell or use the stocks of Fluenz Tetra that you purchase from AstraZeneca then you will have no right to return it to AstraZeneca and/or claim a refund.
|Pack Description||FLUENZ TETRA IHL 10 X 0.2ML NS GB 2020-21|
Date of Preparation: July 2020
Supply of Iressa® (gefitinib) for England, Wales & Northern Ireland
This web page provides information to health care professionals on how to obtain supply of Iressa®
Effective 28 November 2019, a simple PAS price will be applicable to any new patients who are initiated on treatment with IRESSA®. The PAS price will be the net value paid at point of purchase via our distribution agent AAH.
AstraZeneca UK Ltd will continue to provide free packs for those patients who are already receiving IRESSA® through the existing complex patient access scheme (i.e. following on from the single upfront payment). Free packs can be ordered via the AAH SPA portal as per current process.
Below you will find a link to the AAH ordering website:
Supply of Iressa® (gefitinib) for Scotland
IRESSA 250mg film-coated tablets (gefitinib) has been available within Scotland, with effect from 7th December 2015.
Stock can be ordered via our Agent, McKesson UK Pharmaceuticals Ltd on 0344 561 8899 or email: firstname.lastname@example.org
Please be aware that you will need an AAH account through McKesson UK to order.